Overview
Founded in July
2021 in Shanghai, China, Teljane Medical specializes in the research,
development and industrialization of glucose monitoring technologies. The
company combines biosensor engineering with digital health to support more
informed diabetes management.
Its
Instara-1 continuous glucose monitoring (CGM) system uses a wearable sensor to
measure glucose in interstitial fluid and sends readings to a compatible device
every five minutes. With a 15-minute warm-up, Instara-1 is designed to make
continuous glucose insights part of everyday life.
Expertise in
Continuous Glucose Monitoring
Teljane Medical’s
expertise encompasses the following core capabilities:
·
Advanced Biosensor
Engineering: Multidisciplinary
research spanning biochemistry, microelectronics, materials science and
algorithm engineering supports the development of sensitive, long-life
biosensors.
· Wearable CGM
Technology: Instara-1 combines
factory calibration with a compact, 4.5 mm profile for discreet monitoring
without routine user calibration.
· Glucose Monitoring
Accuracy:
Instara-1 has a
reported mean absolute relative difference (MARD) of 8.2%, providing a clinical
measure of its glucose monitoring accuracy.
·
Connected Diabetes
Insights: Glucose alerts,
event logging, remote sharing and reports on glucose trends and time in range
bring daily monitoring data together.
Quality Certifications
Teljane Medical
achieved ISO 13485 and MDSAP certifications in 2024, marking a key milestone in
its medical device quality management.
Global Presence
Teljane’s research
network includes laboratories in Shanghai and Silicon Valley, established in
2021. Its international development includes market expansion and licensing
collaborations, while its partnership with JAT Medical supports the
introduction of CGM technologies to healthcare providers in Saudi Arabia.
Partnership with JAT Medical
The collaboration connects Teljane’s
capabilities in biosensors and digital health with JAT Medical’s focus on
serving healthcare professionals across the Kingdom. Together, we aim to
support a more connected approach to diabetes care through clearer glucose
visibility and more informed clinical discussions.
JAT Medical
partners with Teljane Medical to introduce glucose monitoring solutions to the
Saudi healthcare market and expand our Diabetes Care portfolio.